Chevy Chase Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,141
| Closed | -$3.04M | – | 629 |
|
|
2024
Q2 | $3.04M | Sell |
11,141
-453
| -4% | -$124K | 0.01% | 535 |
|
|
2024
Q1 | $4.01M | Sell |
11,594
-98
| -0.8% | -$33.9K | 0.01% | 529 |
|
|
2023
Q4 | $3.78M | Sell |
11,692
-48
| -0.4% | -$15.5K | 0.01% | 529 |
|
|
2023
Q3 | $4.21M | Sell |
11,740
-539
| -4% | -$193K | 0.02% | 504 |
|
|
2023
Q2 | $4.66M | Sell |
12,279
-233
| -2% | -$88.3K | 0.02% | 503 |
|
|
2023
Q1 | $5.99M | Buy |
12,512
+127
| +1% | +$60.8K | 0.02% | 476 |
|
|
2022
Q4 | $5.21M | Sell |
12,385
-707
| -5% | -$297K | 0.02% | 493 |
|
|
2022
Q3 | $5.46M | Buy |
13,092
+16
| +0.1% | +$6.68K | 0.02% | 479 |
|
|
2022
Q2 | $6.47M | Buy |
13,076
+81
| +0.6% | +$40.1K | 0.03% | 466 |
|
|
2022
Q1 | $7.32M | Buy |
12,995
+37
| +0.3% | +$20.8K | 0.03% | 473 |
|
|
2021
Q4 | $9.79M | Sell |
12,958
-238
| -2% | -$180K | 0.03% | 426 |
|
|
2021
Q3 | $9.84M | Sell |
13,196
-538
| -4% | -$401K | 0.03% | 415 |
|
|
2021
Q2 | $8.85M | Sell |
13,734
-728
| -5% | -$469K | 0.03% | 442 |
|
|
2021
Q1 | $8.26M | Sell |
14,462
-1,033
| -7% | -$590K | 0.03% | 456 |
|
|
2020
Q4 | $9.03M | Sell |
15,495
-365
| -2% | -$213K | 0.03% | 428 |
|
|
2020
Q3 | $8.18M | Sell |
15,860
-1,340
| -8% | -$691K | 0.03% | 417 |
|
|
2020
Q2 | $7.77M | Buy |
+17,200
| New | +$7.77M | 0.03% | 422 |
|